Kolesnik, O. P.; Kuzmenko, V. O. ERCC1 As a Marker of Prognosis and Sensitivity to Platinum-Based Chemotherapy in Patients With Stage III–IV Non-Small Cell Lung Cancer. Pathologia 2020.